Physician profile
Susan E Delean Botkin
NPI 1043306335
$842.24
in general payments reported to CMS, 2019-2025
18 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $192 · 2022: $125 · 2023: $181 · 2024: $105 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $525.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $182.54 | 2021-2024 | |
| Pfizer INC. | $136.30 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $59.87 | 2021-2023 | Farxiga |
| Exact Sciences Corporation | $55.82 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Viatris Specialty LLC | $46.58 | 2025 | Yupelri |
| Lilly USA, LLC | $39.55 | 2022-2024 | Zepbound, Mounjaro |
| Abbvie INC. | $38.72 | 2024-2025 | |
| Astellas Pharma US INC | $38.63 | 2023-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.72 | 2022 | |
| Glaxosmithkline, LLC. | $33.24 | 2022-2023 | Shingrix, Arexvy |
| Takeda Pharmaceuticals U.S.A., INC. | $31.88 | 2021-2022 | |
| Tactile Systems Technology INC | $27.27 | 2025 | Nimbl, Flexitouch Plus |
| Idorsia Pharmaceuticals US INC | $24.61 | 2023 | Quviviq |
| Mylan Specialty L.P. | $24.37 | 2022 | |
| Horizon Therapeutics Plc | $23.12 | 2023 | Krystexxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.20 | 2023 | |
| Novo Nordisk INC | $14.58 | 2023 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Delean Botkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.